Perceptions of psychiatrists toward long-acting injectable antipsychotics: A cross-sectional survey from Fujian, China

Objective: This study aimed to assess the knowledge, attitudes, and willingness of psychiatrists to promote long-acting injectable antipsychotics (LAIs) in Fujian Province, China, and to identify the influencing factors. Methods: A cross-sectional survey was conducted using convenience sampling among psychiatrists attending a provincial conference. An 18-item online questionnaire was distributed via Wenjuanxing. Descriptive statistics, Mann-Whitney U tests and Spearman’s rank correlation were used. Benjamini-Hochberg FDR correction was applied for multiple correlations Results: A total of 222 psychiatrists completed the survey, with 90 respondents (40.5%) identifying as female. The largest age group was 30–39 years (46.9%). Most participants (51.4%) had > 10 years of clinical experience, and 65 (29.3%) held senior professional titles. Most participants reported adequate knowledge of LAIs (96.4%), recognized their therapeutic value (80.2%) and favorable application prospects (87.8%), and expressed a willingness to promote LAIs (82.4%).High cost was identified as the primary barrier to clinical use (90.5%) and the most critical factor for wider adoption (88.3%). Psychiatrists with more clinical experience (>10 years) held significantly more positive attitudes regarding overall therapeutic value, willingness to promote LAIs, and support for early application (all P